AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « line »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
limiting < line < lineage  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000165 (2020) Chao Zhang [République populaire de Chine] ; Meini Zhang [République populaire de Chine] ; Wei Qiu [République populaire de Chine] ; Hongshan Ma [République populaire de Chine] ; Xinghu Zhang [République populaire de Chine] ; Zilong Zhu [République populaire de Chine] ; Chun-Sheng Yang [République populaire de Chine] ; Dongmei Jia [République populaire de Chine] ; Tian-Xiang Zhang [République populaire de Chine] ; Meng Yuan [République populaire de Chine] ; Yan Feng [République populaire de Chine] ; Li Yang [République populaire de Chine] ; Wenli Lu [République populaire de Chine] ; Chunshui Yu [République populaire de Chine] ; Jeffrey L. Bennett [États-Unis] ; Fu-Dong Shi [République populaire de Chine]Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
000204 (2020) Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Lenore Tominna [États-Unis] ; Ibrahim Abbass [États-Unis]Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic.
000208 (2020) Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000218 (2020) Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
000221 (2020) Yao-Chung Liu [Taïwan] ; Ting-An Lin [Taïwan] ; Hao-Yuan Wang [Taïwan] ; Po-Shen Ko [Taïwan] ; Chia-Jen Liu [Taïwan] ; Liang-Tsai Hsiao [Taïwan] ; Sheng-Hsuan Chien [Taïwan] ; Jyh-Pyng Gau [Taïwan]Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
000222 (2020) Paul Emery [Royaume-Uni] ; Sarah Horton [Royaume-Uni] ; Raluca Bianca Dumitru [Royaume-Uni] ; Kamran Naraghi [Royaume-Uni] ; Désirée Van Der Heijde [Pays-Bas] ; Richard J. Wakefield [Royaume-Uni] ; Elizabeth M A. Hensor [Royaume-Uni] ; Maya H. Buch [Royaume-Uni]Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
000299 (2020) Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis]Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties
000324 (2020) Sae Ochi [Japon] ; Kazuyoshi Saito [Japon] ; Fumitaka Mizoguchi [Japon] ; Shigeaki Kato [Japon] ; Yoshiya Tanaka [Japon]Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
000386 (2020) Matthew Mankarious [Royaume-Uni] ; Nick C. Matthews [Royaume-Uni] ; John A. Snowden [Royaume-Uni] ; Arun Alfred [Royaume-Uni]Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
000451 (2020) Yue Zhang ; Qianhao Xu ; Zhuoyan Sun ; Lei ZhouCurrent targeted therapeutics against COVID-19: based on first-line experience in china
000585 (2020) Zakir Khan [Pakistan] ; Yusuf Karata [Turquie] ; Hazir RahmanAnti COVID-19 Drugs: Need for More Clinical Evidence and Global Action

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "line" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "line" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    line
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021